World's Best Scientists 2026 revealed!
Satoshi Minoshima

Satoshi Minoshima

D-Index & Metrics

Medicine

D-Index
90
Citations
44124
World Ranking
11985
National Ranking
6146

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Disease

Alzheimer's disease, Dementia, Nuclear medicine, Positron emission tomography and Internal medicine are his primary areas of study. His Alzheimer's disease research integrates issues from Vesicular acetylcholine transporter, Posterior cingulate and Cholinergic. His Dementia research is multidisciplinary, relying on both Fluorodeoxyglucose, Psychiatry and Prospective cohort study.

His study in Nuclear medicine is interdisciplinary in nature, drawing from both Image processing, Appropriate Use Criteria, Magnetic resonance imaging and Cerebral blood flow. He focuses mostly in the field of Positron emission tomography, narrowing it down to matters related to Differential diagnosis and, in some cases, Frontotemporal dementia. The various areas that Satoshi Minoshima examines in his Internal medicine study include Cardiology, Endocrinology, Oncology and Pathology.

His most cited work include:

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium (3883 citations)
  • Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. (1165 citations)
  • Spatial working memory in humans as revealed by PET (1038 citations)

What are the main themes of his work throughout his whole career to date?

Satoshi Minoshima spends much of his time researching Pathology, Internal medicine, Nuclear medicine, Dementia and Neuroscience. His Pathology research includes elements of Central nervous system disease and In vivo. Satoshi Minoshima combines subjects such as Endocrinology, Posterior cingulate, Oncology and Cardiology with his study of Internal medicine.

His Nuclear medicine study combines topics from a wide range of disciplines, such as Magnetic resonance imaging, Radiology and Cerebral blood flow. His Dementia study integrates concerns from other disciplines, such as Alzheimer's disease, Psychiatry and Intensive care medicine. Much of his study explores Positron emission tomography relationship to Biomedical engineering.

He most often published in these fields:

  • Pathology (20.00%)
  • Internal medicine (20.00%)
  • Nuclear medicine (16.84%)

What were the highlights of his more recent work (between 2014-2021)?

  • Positron emission tomography (13.68%)
  • Internal medicine (20.00%)
  • Dementia (15.26%)

In recent papers he was focusing on the following fields of study:

His main research concerns Positron emission tomography, Internal medicine, Dementia, Magnetic resonance imaging and Amyloid pet. The Positron emission tomography study combines topics in areas such as Brain positron emission tomography and Nuclear magnetic resonance. The concepts of his Internal medicine study are interwoven with issues in Endocrinology, Posterior cingulate, Oncology and Cardiology.

His work carried out in the field of Dementia brings together such families of science as Alzheimer's disease, Nuclear medicine, Database and Intensive care medicine. His Alzheimer's disease research incorporates elements of Molecular imaging and Appropriate Use Criteria. His work in Intensive care medicine covers topics such as Disease which are related to areas like Psychiatry and Early detection.

Between 2014 and 2021, his most popular works were:

  • Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection (162 citations)
  • Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction (72 citations)
  • SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0 (66 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Disease

His primary areas of investigation include Magnetic resonance imaging, Disease, Intensive care medicine, Traumatic brain injury and Pathology. His studies in Disease integrate themes in fields like Biomarker and Psychiatry. His Intensive care medicine research is multidisciplinary, incorporating elements of Dementia and 18f fdg pet.

His Dementia study frequently draws parallels with other fields, such as Alzheimer's disease. His biological study spans a wide range of topics, including Positron emission tomography and Appropriate Use Criteria. His studies deal with areas such as Deep cerebellar nuclei, F 18 fdg pet and Nasal administration as well as Pathology.

Best Publications

  • Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium

    I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre

  • Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment

    Suzanne Craft;Laura D. Baker;Thomas J. Montine;Satoshi Minoshima

  • Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

    Eric M. Reiman;Richard J. Caselli;Lang S. Yun;Kewei Chen

  • A Diagnostic Approach in Alzheimer's Disease Using Three-Dimensional Stereotactic Surface Projections of Fluorine-18-FDG PET

    Satoshi Minoshima;Kirk A. Frey;Kirk A. Frey;Robert A. Koeppe;Norman L. Foster

  • Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.

    Keith A. Johnson;Satoshi Minoshima;Nicolaas I. Bohnen;Kevin J. Donohoe

  • Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation.

    Jürgen Lorenz;S. Minoshima;K. L. Casey

  • Verbal working memory load affects regional brain activation as measured by pet

    John Jonides;Eric H. Schumacher;Edward E. Smith;Erick J. Lauber

  • Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias

    Lisa Mosconi;Wai H. Tsui;Wai H. Tsui;Karl Herholz;Alberto Pupi

  • Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes.

    Laura D. Baker;Donna J. Cross;Satoshi Minoshima;Dana Belongia

  • Brain activation in PTSD in response to trauma-related stimuli.

    Israel Liberzon;Stephan F Taylor;Richard Amdur;Tara D Jung

  • Spatial versus object working memory: Pet investigations

    Edward E. Smith;John Jonides;Robert A. Koeppe;Edward Awh

  • Positron emission tomographic analysis of cerebral structures activated specifically by repetitive noxious heat stimuli

    Kenneth L. Casey;Satoshi Minoshima;Kevin L. Berger;Robert A. Koeppe

  • FDG-PET improves accuracy in distinguishing frontotemporal dementia and Alzheimer's disease

    Norman L. Foster;Judith L. Heidebrink;Christopher M. Clark;William J. Jagust

  • Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

    Alexander Drzezga;Nicola Lautenschlager;Hartwig Siebner;Matthias Riemenschneider

  • Comparison of human cerebral activation pattern during cutaneous warmth, heat pain, and deep cold pain

    Kenneth L. Casey;Satoshi Minoshima;Thomas J. Morrow;Robert A. Koeppe

  • Alzheimer's disease versus Dementia with Lewy bodies : Cerebral metabolic distinction with autopsy confirmation

    Satoshi Minoshima;Norman L. Foster;Anders A. F. Sima;Kirk A. Frey

  • Anatomic Standardization: Linear Scaling and Nonlinear Warping of Functional Brain Images

    Satoshi Minoshima;Robert A. Koeppe;Kirk A. Frey;Kirk A. Frey;David E. Kuhl

  • In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease

    D. E. Kuhl;S. Minoshima;J. A. Fessler;K. A. Frey;K. A. Frey

  • Decrease in parietal cerebral hemoglobin oxygenation during performance of a verbal fluency task in patients with Alzheimer's disease monitored by means of near-infrared spectroscopy (NIRS)--correlation with simultaneous rCBF-PET measurements.

    Christoph Hock;Kersten Villringer;Franz Müller-Spahn;Rüdiger Wenzel

  • In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease

    D.E. Kuhl;R.A. Koeppe;S. Minoshima;S.E. Snyder

Frequent Co-Authors

Robert A. Koeppe
Robert A. Koeppe University of Michigan–Ann Arbor
Kirk A. Frey
Kirk A. Frey University of Michigan–Ann Arbor
David E. Kuhl
David E. Kuhl University of Michigan–Ann Arbor
Norman L. Foster
Norman L. Foster University of Utah
Elaine R. Peskind
Elaine R. Peskind University of Washington
Kenneth L. Casey
Kenneth L. Casey University of Michigan–Ann Arbor
Thomas J. Morrow
Thomas J. Morrow University of Michigan–Ann Arbor
Nicolaas I. Bohnen
Nicolaas I. Bohnen University of Michigan–Ann Arbor
Alexander Drzezga
Alexander Drzezga University of Cologne
Murray A. Raskind
Murray A. Raskind University of Washington

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean becoming a doctor. Many students are turning to related online degrees that offer flexible learning and growing job opportunities in the healthcare sector. For example, you can take online medical coding classes with financial aid, which prepare you for in-demand roles without the high cost of traditional programs.

If you are interested in nursing, you may ask, do I need to take the TEAS test for LPN? Some nursing schools have relaxed entrance requirements, making it more accessible to launch a nursing career.

For those wanting to advance quickly, accelerated healthcare administration degree online options can help you move into leadership roles in less time. Registered nurses hoping to become nurse practitioners can explore an RN to NP bridge program, creating a smooth path toward advanced clinical roles.

Whether you prefer clinical or administrative routes, these online pathways offer flexibility and new opportunities in the evolving healthcare landscape.

Best Scientists Citing Satoshi Minoshima

Trending Scientists

Recently Published Articles